Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

FDA clears Pluristem's IND application for PLX-R18 to treat acute radiation syndrome

May 2, 2018

Accelerator Life Science Partners launches Proniras

April 30, 2018

Researchers present gene therapy for methamphetamine-induced inflammation

April 27, 2018

Pear Therapeutics and Sandoz sign agreement for prescription digital therapeutics

April 19, 2018

Opiant Pharmaceuticals receives grant to develop intranasal nalmefene

April 19, 2018

AntoXa Corporation obtains license from DRDC for plant-made PhD9 anti-ricin antibody

April 19, 2018

Humanetics obtains NIAID grant to support development of BIO-300 as a medical countermeasure

April 13, 2018

FDA approves Leukine for H-ARS

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...